SeaBridge Investment Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-50
Closed -$14K 142
2020
Q3
$14K Buy
+50
New +$13.9K 0.01% 219
2016
Q4
Sell
-169
Closed -$53K 249
2016
Q3
$53K Sell
169
-21,366
-99% -$6.33M 0.01% 171
2016
Q2
$5.21M Buy
21,535
+150
+0.7% +$39.5K 1.32% 24
2016
Q1
$5.57M Buy
21,385
+1,158
+6% +$306K 1.35% 24
2015
Q4
$6.2M Buy
20,227
+4,217
+26% +$1.21M 1.38% 22
2015
Q3
$4.67M Buy
+16,010
New +$5.29M 1.09% 36

Other funds holding BIIB

SeaBridge Investment Advisors's BIIB Position: Q4 2020 in Review

SeaBridge Investment Advisors sold out of Biogen (BIIB) in Q4 2020, closing a stake of 50 shares — an estimated $14K sold.

SeaBridge Investment Advisors first reported a position in BIIB in Q3 2015 and held it in 6 quarters. The position peaked at $6.2M in Q4 2015. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • SeaBridge Investment Advisors reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • SeaBridge Investment Advisors sold 50 Biogen shares in Q4 2020, an estimated $14K.
  • SeaBridge Investment Advisors first reported a position in Biogen in Q3 2015 and held it in 6 quarters.
  • SeaBridge Investment Advisors's Biogen position peaked at $6.2M in Q4 2015.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on SeaBridge Investment Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.